유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

sanofi winthrop industrie - inzulín glargine, lixisenatide - diabetes mellitus, typ 2 - lieky používané pri cukrovke - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

astellas pharma europe b.v. - enzalutamide - prostatické nádory - endokrinná terapia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

santen oy, fínsko - tafluprost - 64 - ophthalmologica

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

santen oy, fínsko - tafluprost - 64 - ophthalmologica

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva, k.s., Česká republika - escitalopram - 30 - antidepressiva

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

accord healthcare s.l.u. - icatibant acetate - angioedémy, dedičné - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glenmark pharmaceuticals s.r.o., Česká republika - ikatibant - 87 - varia i

슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva, k.s., Česká republika - ikatibant - 87 - varia i

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

octapharma ab - simoctocog alfa - hemofília a - krvné faktory koagulácie - liečba a profylaxia krvácania u pacientov s hemofíliou a (vrodená deficiencia faktora viii). nuwiq môžu byť použité pre všetky vekové skupiny.

유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

omrix biopharmaceuticals n. v. - ľudský fibrinogén, ľudský trombín - hemostáza - miestne hemostatics - podporná liečba v chirurgii dospelých, kde štandardné chirurgické techniky nie sú dostatočné (pozri časť 5). 1):- pre zlepšenie hemostázu.